Skip to main content
Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.010
+0.070 (3.61%)
At close: Nov 22, 2024, 4:00 PM
2.000
-0.010 (-0.50%)
After-hours: Nov 22, 2024, 7:15 PM EST

Virax Biolabs Group Revenue

Virax Biolabs Group had revenue of $79.92K in the half year ending March 31, 2024. This brings the company's revenue in the last twelve months to $84.87K, up 7.03% year-over-year. In the fiscal year ending March 31, 2024, Virax Biolabs Group had annual revenue of $156.42K with 1,727.11% growth.

Revenue (ttm)
$84.87K
Revenue Growth
+7.03%
P/S Ratio
61.04
Revenue / Employee
$4,992
Employees
17
Market Cap
8.73M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024156.42K147.86K1,727.11%
Mar 31, 20238.56K--
Mar 31, 2022---
Mar 31, 2021123.82K23.94K23.97%
Mar 31, 202099.88K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Precipio 17.41M
Evogene 7.48M
COSCIENS Biopharma 4.83M
Ensysce Biosciences 4.42M
NeuroMetrix 3.77M
RedHill Biopharma 3.71M
Onconetix 1.46M
Revenue Rankings

VRAX News

More News